Early research (Phase 1)Study completedNCT00858611
What this trial is testing
VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat...
Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 51